dc.contributor.author |
Serafim, Ricardo A. M. |
|
dc.contributor.author |
Gehringer, Matthias |
|
dc.date.accessioned |
2025-07-21T08:38:31Z |
|
dc.date.available |
2025-07-21T08:38:31Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
1424-8247 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/168235 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Basel : Mdpi |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3390/ph17020206 |
de_DE |
dc.subject.ddc |
540 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20240422000000_00735 |
|
utue.personen.roh |
Serafim, Ricardo A. M. |
|
utue.personen.roh |
Gehringer, Matthias |
|
utue.personen.roh |
Borsari, Chiara |
|
dcterms.isPartOf.ZSTitelID |
Pharmaceuticals |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 206 |
de_DE |
dcterms.isPartOf.ZS-Volume |
17 (2) |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |